| View |
|
DRP-8724-01
|
Etoposide
|
Reseda
|
20 mg/ mL (100 mg/ 5 mL)
|
Solution for Injection (IV)
|
Antineoplastic (Podophyllotoxin derivative)
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
23 August 2024
|
21 February 2026
|
| View |
|
DRP-8745-07
|
Cefuroxime (as sodium)
|
Marfuroxime
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
08 September 2024
|
20 February 2025
|
| View |
|
DRP-8802-02
|
Paclitaxel
|
PaxHealth 100
|
6 mg/mL (100mg/16.7 mL)
|
Solution for Intravenous Infusion
|
Antineoplastic (Cell cycle-specific agent)
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
04 September 2024
|
03 October 2028
|
| View |
|
DRP-8900-04
|
Sitagliptin (as phosphate)
|
Kozta
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Sai Mirra Innopharm Pvt. Ltd.
|
India
|
CLIDP Conversion
|
31 August 2024
|
08 June 2030
|
| View |
|
DRP-9636-02
|
Sevelamer Carbonate
|
Xelafos
|
800 mg
|
Film-Coated Tablet
|
Drug for treatment of hyperkalemia and hyperphosphatemia
|
Pharose Remedies Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
21 April 2026
|
| View |
|
HRP-537
|
Hydroquinone + Tretinoin
|
Extrapeel (Exfoliant Solution 1)
|
2 g (2% w/v)/10 mg (0.01% w/v)
|
Topical Solution
|
Anti-Acne/Keratolytic/Depigmenting Agent
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
08 September 2024
|
19 August 2029
|
| View |
|
DRP-5060-05
|
Cefuroxime (as Sodium)
|
Cefuvil
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial
|
Zhuhai Kinhoo Pharmaceutical Co., Ltd.
|
China
|
-
|
19 April 2023
|
14 October 2026
|
| View |
|
DRP-10067-01
|
Losartan Potassium
|
Retasar
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Emil Pharmaceutical Industries Pvt. Ltd.
|
India
|
CLIDP Conversion
|
23 September 2024
|
26 May 2028
|
| View |
|
DRP-10077-03
|
Rosuvastatin (as calcium)
|
Vastros-20
|
20 mg
|
Tablet
|
Antihyperlipidemic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
06 October 2025
|
| View |
|
DRP-10383-01
|
Cefixime (as trihydrate)
|
Hypercef
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
24 September 2024
|
02 December 2029
|
| View |
|
DRP-10383-02
|
Cefixime (as trihydrate)
|
Unixime
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
25 September 2024
|
02 December 2029
|
| View |
|
DRP-10540-01
|
Iron (as Ferrous fumarate) + Vitamin B-complex
|
None
|
(see reverse)
|
Capsule
|
Vitamins and Minerals
|
Drugmaker's Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
15 September 2024
|
28 December 2026
|
| View |
|
DRP-10720-01
|
Dapagliflozin
|
Forfloz
|
5 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2 (SGLT2) inhibitor]
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
24 September 2024
|
11 November 2026
|
| View |
|
DRP-10721-10
|
Dapagliflozin
|
Lupizin
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2 (SGLT2) Inhibitor]
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
23 September 2024
|
11 November 2026
|
| View |
|
DRP-10748-03
|
Atorvastatin (as calcium)
|
Retavastatin
|
40 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
23 September 2024
|
15 November 2026
|
| View |
|
DRP-1077-23
|
Co-Amoxiclav
|
Moxibam
|
625 mg
|
Tablet
|
Antibacterial (Penicillin)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
23 September 2024
|
07 October 2028
|
| View |
|
DRP-10874-04
|
Ceftriaxone (as sodium) + Sulbactam (as sodium)
|
Vertam
|
1 g / 500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin - Beta-Lactamase Inhibitor Combination)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
27 September 2024
|
10 December 2026
|
| View |
|
DRP-10878-10
|
Clopidogrel (as bisulfate)
|
Clopierra
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
10 December 2026
|
| View |
|
DRP-11044-10
|
Potassium Citrate
|
Techtrate
|
1080 mg
|
Extended-Release Tablet
|
Antiurolithic
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
15 September 2024
|
18 January 2027
|
| View |
|
DRP-11044-11
|
Potassium Citrate
|
Keltasy
|
1080 mg
|
Extended-Release Tablet
|
Antiurolithic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
18 January 2027
|